Summary: New research suggests that recovery after a traumatic brain injury (TBI) may begin in the gut. A brief course of antibiotics in animal models remodeled the gut microbiome, reduced neuroinflammation and limited brain cell death, pointing to a gut–brain mechanism that influences healing after TBI.
By reshaping the microbial community in the intestines, the treatment reduced harmful bacteria and allowed beneficial species—especially Parasutterella excrementihominis and Lactobacillus johnsonii—to persist. These bacteria appear to modulate peripheral immune responses and help prevent the gut–brain axis from transmitting damaging inflammatory signals that can impede neural repair.
Key Facts
- The antibiotic effect: Short-term antibiotics given after TBI reduced lesion size and limited neurodegeneration, apparently by suppressing inflammatory gut bacteria.
- Important microbes: The taxa Parasutterella excrementihominis and Lactobacillus johnsonii were identified as resilient after treatment and linked to cellular repair and regulation of inflammation.
- Immune connection: A large portion of immune system regulation originates in the gut, making microbiome balance a key factor in the brain’s recovery process.
- Disrupted signaling: TBI can scramble bidirectional signals along the gut–brain axis; persistent gut imbalance may create a feedback loop that worsens neuroinflammation.
- Long-term implications: Interrupting acute inflammatory cycles after injury may lower the long-term risk of neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases.
Source: Houston Methodist
Could brain recovery after traumatic injury begin in the gut?
A new study published in Nature Communications Biology by researchers at Houston Methodist, led by Sonia Villapol, Ph.D., shows that a short course of oral antibiotics following traumatic brain injury markedly reduced neuroinflammation and neurodegeneration in animal models by altering the gut microbiome.
“We found that antibiotic treatment following TBI reduced harmful gut bacteria, decreased lesion size and limited cell death,” said Villapol, an associate professor in the Department of Neurosurgery at Houston Methodist. “Our results support a gut–brain mechanism in which microbiome changes influence peripheral immunity and, in turn, neuroinflammation after TBI.”
In the study, antibiotic therapy lowered the abundance of many gut bacteria and shifted microbial diversity, particularly after repeated injuries. Despite this reduction in overall bacterial counts, two taxa—Parasutterella excrementihominis and Lactobacillus johnsonii—persisted and were associated with protective effects in the brain. The researchers propose these microbes help drive cell repair and regulate peripheral inflammation that would otherwise amplify neuroinflammatory responses.
The gut’s role in immunity is substantial—estimates indicate that roughly 70% of immune system regulation originates in the gut microbiome. When the gut ecosystem becomes imbalanced, the bidirectional gut–brain axis can propagate damaging signals to other organs. “After a traumatic brain event, the brain’s signals can become scrambled and disrupt organs including the digestive system,” Villapol explained. “If the gut remains out of balance, the brain may struggle to heal.”
TBI affects millions each year, and growing evidence links post-injury gut dysbiosis to longer-term risks for neurodegenerative disorders. The authors note that persistent neuroinflammation following TBI could act as a chronic driver of pathology that contributes to conditions such as Alzheimer’s and Parkinson’s disease.
Villapol’s laboratory is working to translate these findings into neuroprotective strategies that reduce inflammation after injury. The next steps will include efforts to bioengineer or otherwise harness P. excrementihominis and L. johnsonii for precision therapies aimed at improving outcomes after TBI.
Collaborators on the study include Hannah Flinn, Austin Marshall, Morgan Holcomb, Marissa Burke, Goknur Kara, Leonardo Cruz-Pineda, Sirena Soriano and Todd J. Treangen. Funding sources included the Houston Methodist Research Institute and the National Institutes of Health.
Key Questions Answered:
A: Although it may seem counterintuitive, the gut controls a large portion of immune regulation. After a brain injury, stress signals can favor harmful bacteria in the gut. Short-term antibiotics can reset that microbial balance, allowing beneficial microbes to produce signals that reduce inflammation and support brain repair.
A: The study highlights two specific bacteria—P. excrementihominis and L. johnsonii—that appear particularly important. General probiotics may be beneficial, but future treatments will likely focus on precision approaches that target or engineer specific strains for TBI recovery.
A: Emerging research suggests chronic gut dysfunction after TBI can promote sustained neuroinflammation, which may contribute over time to neurodegenerative diseases such as Alzheimer’s and Parkinson’s. More research is needed to define causality and therapeutic windows.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by editorial staff.
About this neurology research news
Author: Ashley White
Source: Houston Methodist
Contact: Ashley White – Houston Methodist
Image: Image credited to Neuroscience News
Original Research: Open access.
Title: Antibiotic-induced gut microbiome remodeling reduces neuroinflammation in traumatic brain injury
Authors: Hannah Flinn, Austin Marshall, Morgan Holcomb, Marissa Burke, Goknur Kara, Leonardo Cruz-Pineda, Sirena Soriano, Todd J. Treangen & Sonia Villapol.
DOI: 10.1038/s42003-026-09737-1
Abstract
Antibiotic-induced gut microbiome remodeling reduces neuroinflammation in traumatic brain injury
Traumatic brain injury triggers neuroinflammation and disrupts the gut microbiome, but the effects of short-term antibiotic treatment on these processes have been unclear. To investigate, the researchers administered controlled brain injuries to male mice and followed with a brief oral antibiotic regimen.
Antibiotic exposure reduced bacterial abundance in feces and changed microbial diversity, with larger shifts observed after repeated injuries. Despite reduced overall bacterial counts, mice treated with antibiotics showed smaller brain lesion volumes, less cell death, diminished activation of microglia and macrophages, lower pro-inflammatory cytokine levels, reduced astrogliosis, and decreased infiltration of peripheral immune cells compared with vehicle-treated mice after two injuries.
In the gut, more severe injury correlated with villus shortening and loss of mucus-producing cells; antibiotics further modified these injury-related intestinal changes. Levels of circulating short-chain fatty acids and related microbial metabolic functions fell after antibiotic exposure. By contrast, germ-free mice experienced larger lesion volumes and worse gliosis after brain injury. Long-read metagenomic sequencing identified Parasutterella excrementihominis and Lactobacillus johnsonii as taxa that persisted despite antibiotic treatment.
Together, these findings indicate that short-term antibiotics can reduce brain damage after injury through mechanisms not solely explained by short-chain fatty acids, while also emphasizing potential drawbacks of altering the gut microbiome and the need for targeted therapeutic strategies.